ADVM-053

N/A

Report date: 2023/10/26 16:47:26

Base Information

Drug NameADVM-053
Drug Alias NameANN-002AAVrh10-C1EI
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionComplement C1 inhibitorsGene transference
TargetsComplement C1
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeill Cornell Medical College
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdverum Biotechnologies Inc
Active IndicationsN/A
Inactive IndicationsAngioedemas, Hereditary

Other Information

ATC CodeN/A
Related LinksN/A